AN2 Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $70,000,000.00 in Post-IPO Equity.
According to filings with the U.S. Securities and Exchange Commission, AN2 Therapeutics is raising $70,000,000.00 in new funding. About AN2 Therapeutics: AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic,…